China National Medicines Corp Ltd (600511) — Tangible Net Worth Ratio
China National Medicines Corp Ltd (600511) has a Tangible Net Worth Ratio of 98.2% as of September 2025. This metric is calculated by deducting intangible assets (CN¥366.68 Million) from net assets (CN¥19.93 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See what is China National Medicines Corp Ltd's book value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
China National Medicines Corp Ltd Tangible Net Worth Ratio (1999–2024)
This chart shows how China National Medicines Corp Ltd's Tangible Net Worth Ratio has changed across 26 annual periods from 1999 to 2024. As of September 2025, the ratio stands at 98.2%, reflecting net assets of CN¥19.93 Billion with intangible assets of CN¥366.68 Million CNY. Also explore net asset momentum of China National Medicines Corp Ltd to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for China National Medicines Corp Ltd (1999–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for China National Medicines Corp Ltd from 1999 to 2024, covering 26 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see China National Medicines Corp Ltd (600511) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 97.9% | CN¥18.98 Billion | CN¥391.56 Million | CN¥34.93 Billion | ▲ +0.1 pp |
| 2023 | 97.8% | CN¥17.53 Billion | CN¥386.10 Million | CN¥32.45 Billion | ▼ -0.1 pp |
| 2022 | 97.9% | CN¥15.86 Billion | CN¥330.91 Million | CN¥29.61 Billion | ▲ +0.2 pp |
| 2021 | 97.7% | CN¥14.36 Billion | CN¥326.21 Million | CN¥27.48 Billion | ▲ +0.3 pp |
| 2020 | 97.5% | CN¥13.09 Billion | CN¥330.38 Million | CN¥24.90 Billion | ▲ +0.1 pp |
| 2019 | 97.3% | CN¥12.16 Billion | CN¥324.45 Million | CN¥24.19 Billion | ▲ +0.0 pp |
| 2018 | 97.3% | CN¥10.61 Billion | CN¥287.28 Million | CN¥21.51 Billion | ▲ +0.2 pp |
| 2017 | 97.1% | CN¥9.46 Billion | CN¥278.74 Million | CN¥20.17 Billion | ▼ -0.5 pp |
| 2016 | 97.6% | CN¥4.02 Billion | CN¥96.46 Million | CN¥7.40 Billion | ▲ +0.3 pp |
| 2015 | 97.3% | CN¥3.51 Billion | CN¥94.19 Million | CN¥6.56 Billion | ▲ +0.7 pp |
| 2014 | 96.6% | CN¥2.58 Billion | CN¥87.73 Million | CN¥5.54 Billion | ▼ -0.1 pp |
| 2013 | 96.7% | CN¥2.20 Billion | CN¥73.34 Million | CN¥5.08 Billion | ▲ +0.5 pp |
| 2012 | 96.2% | CN¥1.87 Billion | CN¥71.74 Million | CN¥4.56 Billion | ▼ -3.1 pp |
| 2011 | 99.3% | CN¥1.53 Billion | CN¥10.97 Million | CN¥3.55 Billion | ▲ +0.1 pp |
| 2010 | 99.2% | CN¥1.34 Billion | CN¥11.10 Million | CN¥3.39 Billion | ▲ +0.1 pp |
| 2009 | 99.1% | CN¥1.08 Billion | CN¥9.73 Million | CN¥2.78 Billion | ▲ +0.5 pp |
| 2008 | 98.6% | CN¥868.25 Million | CN¥11.91 Million | CN¥2.00 Billion | ▼ -0.7 pp |
| 2007 | 99.3% | CN¥725.96 Million | CN¥5.15 Million | CN¥1.96 Billion | ▲ +0.4 pp |
| 2006 | 98.9% | CN¥590.99 Million | CN¥6.56 Million | CN¥1.36 Billion | ▲ +0.2 pp |
| 2005 | 98.7% | CN¥521.33 Million | CN¥6.63 Million | CN¥1.28 Billion | ▼ -0.6 pp |
| 2004 | 99.3% | CN¥488.38 Million | CN¥3.39 Million | CN¥1.19 Billion | ▼ 0.0 pp |
| 2003 | 99.3% | CN¥468.65 Million | CN¥3.17 Million | CN¥1.09 Billion | ▼ -0.3 pp |
| 2002 | 99.6% | CN¥399.62 Million | CN¥1.56 Million | CN¥808.37 Million | ▼ -0.4 pp |
| 2001 | 100.0% | CN¥134.77 Million | CN¥0.00 | CN¥435.76 Million | ▲ +0.0 pp |
| 2000 | 100.0% | CN¥124.50 Million | CN¥0.00 | CN¥382.83 Million | ▲ +0.0 pp |
| 1999 | 100.0% | CN¥122.05 Million | CN¥47.19K | CN¥570.85 Million | — |